$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
维莫非尼(威罗非尼)说明书
2025-10-19 11:44:20
Check Details
维莫非尼(佐博伏)适应症
2025-10-19 11:44:20
Check Details
维莫非尼(佐博伏)怎么买?
2025-10-19 11:44:20
Check Details
维莫非尼(威罗非尼)作用功效
2025-10-19 11:44:20
Check Details
维莫非尼(佐博伏)的用法用量
2025-10-19 11:44:20
Check Details
维莫非尼国内何时上市?
2025-10-19 11:44:20
Check Details
Ⅲ期黑色素瘤:达拉非尼加曲美替尼,无复发率高达52%!
2025-10-19 11:44:20
Check Details
黑色素瘤:纳武单抗单药或联合易普利姆玛治疗可显著改善患者的无复发生存
2025-10-19 11:44:20
Check Details
Mekinist国内什么时候上市?
2025-10-19 11:44:20
Check Details
迈吉宁纳入医保目录了吗?
2025-10-19 11:44:20
Check Details
迈吉宁什么时候上市呢?
2025-10-19 11:44:20
Check Details
威罗菲尼在治疗黑色素瘤这方面疗效如何?
2025-10-19 11:44:20
Check Details
1
2
...
551
552
553
554
555
556
557
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
2
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
3
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
4
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
5
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
6
Cemiplimab (Libtayo) Drug Information
7
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
8
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
9
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
10
A Revolutionary Targeted Therapy for Hematological Malignancies
11
A New Option for Advanced Renal Cell Carcinoma Treatment
12
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description: